The global Biologics Market is estimated to be valued at US$ 401.96 billion in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period 2023-2030.
A) Market Overview:
The biologics market comprises a diverse range of products including monoclonal antibodies, vaccines, cell and gene therapies, and recombinant proteins. These products are derived from living organisms or contain...
0 Commentarios
0 Acciones
1685 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian